Drug · DIN 02417456
LOLO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 6, 2024; first marketed March 24, 2014.
- Drug Identification Number (DIN)
- 02417456
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Norethisterone and estrogen G03AB04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NORETHINDRONE ACETATE | 1 MG | |
| ETHINYL ESTRADIOL | 10 MCG | |
| ETHINYL ESTRADIOL | 10 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 1, 2022: NOC 28872New Drug Submission (NDS) · Administrative: Merger/Buy-out
- July 11, 2018: NOC 21084New Drug Submission (NDS) · Merger - buyout
- July 11, 2017: NOC 19518New Drug Submission (NDS)
- December 12, 2013: NOC 15027New Drug Submission (NDS)